Vascular dysfunction—The disregarded partner of Alzheimer's disease
University of Southern California · Huntington Medical Research Institutes · +75 more institutions
Abstract
Increasing evidence recognizes Alzheimer's disease (AD) as a multifactorial and heterogeneous disease with multiple contributors to its pathophysiology, including vascular dysfunction. The recently updated AD Research Framework put forth by the National Institute on Aging-Alzheimer's Association describes a biomarker-based pathologic definition of AD focused on amyloid, tau, and neuronal injury. In response to this article, here we first discussed evidence that vascular dysfunction is an important early event in AD pathophysiology. Next, we examined various imaging sequences that could be easily implemented to evaluate different types of vascular dysfunction associated with, and/or contributing to, AD…
Citation impact
- FWCI
- 60.45
- Percentile
- 100%
- References
- 106
Authors
69Topics & keywords
- Pathophysiology
- Disease
- Dementia
- Medicine
- Biomarker
- Vascular dementia
- Neuroscience
- Cerebral blood flow
Funding
- AAAlzheimer's Association
- HAHeart and Stroke Foundation of Canada
- UOUniversity of Southern California
- CACure Alzheimer's FundAward: 16 CVD 05
- SRSunnybrook Research Institute
- UOUniversity of Toronto
- NINational Institutes of HealthAwards: P50AG005142, NS089323, P30AG049638, R01NS034467, R01AG039452, 1R01NS100459, R01HL096814, R01NS090904, R01AG023084, 5P50AG005142, 5P01AG052350, AG005131, R37-NS089323, R01-NS100447
- MRMedical Research CouncilAwards: MR/L023784/2, MR/J006971/1, MR/K015397/1